PL2366379T3 - Formulacja cefdiniru o lepszej prędkości rozpuszczania - Google Patents
Formulacja cefdiniru o lepszej prędkości rozpuszczaniaInfo
- Publication number
- PL2366379T3 PL2366379T3 PL11156115T PL11156115T PL2366379T3 PL 2366379 T3 PL2366379 T3 PL 2366379T3 PL 11156115 T PL11156115 T PL 11156115T PL 11156115 T PL11156115 T PL 11156115T PL 2366379 T3 PL2366379 T3 PL 2366379T3
- Authority
- PL
- Poland
- Prior art keywords
- dissolution rate
- improved dissolution
- cefdinir
- formulation
- cefdinir formulation
- Prior art date
Links
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 title 1
- 229960003719 cefdinir Drugs 0.000 title 1
- 238000004090 dissolution Methods 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2010/01417A TR201001417A1 (tr) | 2010-02-25 | 2010-02-25 | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu |
| EP11156115.5A EP2366379B1 (en) | 2010-02-25 | 2011-02-25 | Cefdinir formulation with improved dissolution rate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2366379T3 true PL2366379T3 (pl) | 2015-09-30 |
Family
ID=42583992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11156115T PL2366379T3 (pl) | 2010-02-25 | 2011-02-25 | Formulacja cefdiniru o lepszej prędkości rozpuszczania |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2366379B1 (pl) |
| ES (1) | ES2540815T3 (pl) |
| PL (1) | PL2366379T3 (pl) |
| TR (1) | TR201001417A1 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201009165A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefdinir içeren tabletler |
| TR201010859A2 (tr) * | 2010-11-05 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Sefdinir içeren tablet formları. |
| TR201010212A2 (tr) * | 2010-12-08 | 2012-06-21 | Bi̇lgi̇ç Mahmut | Sefdinir içeren katı oral dozaj formu. |
| US10835495B2 (en) | 2012-11-14 | 2020-11-17 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide material and methods of making and using the same |
| CN104116713B (zh) * | 2013-04-24 | 2016-10-19 | 南京亿华药业有限公司 | 一种头孢地尼颗粒及其制备方法 |
| CN109481415A (zh) * | 2018-12-21 | 2019-03-19 | 广州白云山天心制药股份有限公司 | 一种头孢地尼胶囊剂及其制备方法 |
| CN114681414A (zh) * | 2020-12-28 | 2022-07-01 | 北京新领先医药科技发展有限公司 | 一种头孢地尼分散片药物组合物及其制备工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8323034D0 (en) | 1983-08-26 | 1983-09-28 | Fujisawo Pharmaceutical Co Ltd | 7-substituted-3-vinyl-3-cephem compounds |
| US6423341B1 (en) * | 1996-02-29 | 2002-07-23 | Fujisawa Pharmaceutical Co., Ltd. | β-lactam antibiotic-containing tablet and production thereof |
| US20070160675A1 (en) * | 1998-11-02 | 2007-07-12 | Elan Corporation, Plc | Nanoparticulate and controlled release compositions comprising a cephalosporin |
| BR0207640A (pt) * | 2001-02-27 | 2004-07-27 | Ranbaxy Lab Ltd | Composição farmacêutica oral de cefpodoxima proxetil |
| BR0318535A (pt) | 2003-09-30 | 2006-09-12 | Lupin Ltd | composição farmacêutica para o envio controlado de droga, processo para a preparação de uma composição farmacêutica e composição de liberação controlada |
| US20050131079A1 (en) | 2003-12-10 | 2005-06-16 | Pujara Chetan P. | Cefdinir oral suspension |
| GB2421024A (en) * | 2004-12-07 | 2006-06-14 | Sandoz Ag | Cefdinir crystalline form C |
| US20070128268A1 (en) * | 2005-12-07 | 2007-06-07 | Herwig Jennewein | Pharmaceutical compositions comprising an antibiotic |
-
2010
- 2010-02-25 TR TR2010/01417A patent/TR201001417A1/xx unknown
-
2011
- 2011-02-25 ES ES11156115.5T patent/ES2540815T3/es active Active
- 2011-02-25 EP EP11156115.5A patent/EP2366379B1/en active Active
- 2011-02-25 PL PL11156115T patent/PL2366379T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR201001417A1 (tr) | 2011-09-21 |
| EP2366379B1 (en) | 2015-04-08 |
| ES2540815T3 (es) | 2015-07-13 |
| EP2366379A1 (en) | 2011-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2786756T3 (en) | Kombinationsterapi med en topoisomeraseinhibitor | |
| IL245328B (en) | A pharmaceutical preparation containing carbatocin | |
| GB201015079D0 (en) | Novel use | |
| GB201010193D0 (en) | Medicinal use | |
| SG10201507079WA (en) | Syringe | |
| GB2481881B (en) | Liquid formulations | |
| IL222087A (en) | A fast-dissolving pharmaceutical preparation | |
| GB2486567B (en) | Pharmaceutical formulation | |
| ZA201206589B (en) | Incotine containing formulation | |
| IL222086A (en) | A pharmaceutical composition that melts quickly | |
| PL2366379T3 (pl) | Formulacja cefdiniru o lepszej prędkości rozpuszczania | |
| ZA201301950B (en) | Bvdv vaccine | |
| ZA201206924B (en) | Novel use | |
| IL220850A0 (en) | Pigmentation-preventing or-ameliorating agent | |
| SI2642980T1 (sl) | Pediatrične formulacije | |
| ZA201105990B (en) | Anchoring device | |
| GB201006326D0 (en) | Formulation | |
| PL391543A3 (pl) | Kotew | |
| GB2479143B (en) | Reminder device | |
| GB201005992D0 (en) | Formulation | |
| GB201001978D0 (en) | Formulation | |
| GB201002000D0 (en) | Formulation | |
| AU5131P (en) | Parjoy Camellia sasanqua | |
| AU5132P (en) | Pareli Camellia sasanqua | |
| GB201001670D0 (en) | Use |